Aptose Biosciences (NASDAQ:APTO) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research report sent to investors on Thursday. The firm issued a sell rating on the biotechnology company’s stock. APTO has been the subject of a number of other research reports. Alliance Global Partners raised shares of Aptose Biosciences to a […]
StockNews.com began coverage on shares of Aptose Biosciences (NASDAQ:APTO – Free Report) (TSE:APS) in a research report sent to investors on Thursday. The firm issued a sell rating on the biotechnology company’s stock. APTO has been the subject of a number of other research reports. Alliance Global Partners raised shares of Aptose Biosciences to a […]
